神经药理学报››2022,Vol. 12››Issue (2): 9-.DOI:10.3969/j.issn.2095-1396.2022.02.002

• 研究论文 •上一篇下一篇

黄甲软肝颗粒对小鼠急性肝损伤和肝纤维化的保护作用研究

高晓新,李雪梅,王佳帅,等

  1. 北京市药品检验研究院药理毒理室,国家药品监督管理局创新药物安全研究与评价重点实验 室,中药成分分析与生物评价北京市重点实验室,北京,102206,中国
  • 出版日期:2022-04-26发布日期:2022-04-26
  • 通讯作者:李雪梅,硕士研究生,副主任药师;研究方向:药品检验和药物临床前安全;E-mail:cai_di_48@163.com
  • 作者简介:高晓新,硕士研究生,副主任药师;研究方向:药理毒理学和病理学;E-mail:gaoxiaoxin_77@sina.com

Protective Effect of Huangjiaruangan Granule on Acute Liver Injury and Liver Fibrosis in Mice

GAO Xiao-xin,LI Xue-mei,WANG Jia-shuai,et al

  1. Beijing Institute for Drug Control,NMPA Key Laboratory for Safety Research and Evaluation of Innovative Drug, Beijing Key Laboratory of Analysis and Evaluation on Chinese Medicine,Beijing,102206,China
  • Online:2022-04-26Published:2022-04-26

摘要:

目的:研究黄甲软肝颗粒对D- 氨基半乳糖(D-galactosamine,D-Gal N)诱导小鼠急性肝损伤和刀豆素 蛋白A(concanavalin A,Con A)诱导的小鼠肝纤维化的保护作用。 方法:急性肝损伤保护作用实验:84 只ICR 小鼠随机分为阴性对照组、模型组、阳性药组,黄甲软肝颗粒高、中、低剂量组。灌胃给药,每天1 次,连续14 d, 阴性对照组及模型组灌胃同体积去离子水。给药后d 13,除阴性对照组外,其余动物腹腔注射D-Gal N,建立急 性肝损伤模型。于末次给药后60 min,取血并剖检。肝纤维化保护作用实验:96 只BALB/c 小鼠随机分成阴性 对照组、模型组、阳性药组、黄甲软肝颗粒高、中、低剂量组。除阴性对照组以外的动物按照尾静脉注射Con A,阴 性对照组动物注射同体积的无菌PBS,每周注射1 次,共注射7 次。于第4 次注射当天,各组开始灌胃给药,每天 1 次,连续4 w,阴性对照组及模型组灌胃同体积的去离子水,于末次给药后24 小时,取血并剖检。两次实验均 测定血清丙氨酸氨基转移酶(alanine aminotransferase,ALT)和门冬氨酸氨基转移酶(aspartate aminotransferase, AST),摘取肝脏、脾脏称重计算脏器指数、观察肝脏组织病理改变。 结果:急性肝损伤保护作用实验中各给药组 血清ALT、AST 较模型组显著降低、各给药组脾脏指数明显减小、肝损伤程度明显减轻;肝纤维化保护作用实验 中黄甲软肝颗粒高、中剂量组血清ALT、AST 较模型组显著降低,中剂量组肝指数明显减小。 结论:黄甲软肝颗 粒对小鼠急性肝损伤和肝纤维化均具有一定的保护作用。

关键词:黄甲软肝颗粒,氨基半乳糖,刀豆素蛋白A,急性肝损伤,肝纤维化,保护作用

Abstract:

Objective:To study the protective effect of Huangjiaruangan granule on the acute liver injury induced by D-galactosamine (D-Gal N) and the liver fibrosis induced by Con A. Methods:Test method for protective effect of acute liver injury:Eighty-four ICR mice were randomly divided into negative control group,model group,positive drug group,and high-dose, medium-dose and low-dose huangjiarangan granule groups. The negative control group and model group were given the same volume of deionized water by intragastric administration,once a day for 14 consecutive days. On day 13 after administration,all animals except the negative control group were intraperitoneally injected with D-Gal N to establish acute liver injury model. Blood samples were collected and necrotized 60 minutes after the last administration. Test method for protective effect of liver fibrosis:96 BALB/ c mice were randomly divided into negative control group,model group,positive drug group,Huangjiarangan granule high-dose,medium-dose and low-dose groups. Animals except the negative control group were injected with Con A according to tail vein,and animals in the negative control group were injected with sterile PBS of the same volume,once a week,7 times in total. On the day of the fourth injection,each group was given intragastric administration,once a day,for 4 weeks. The negative control group and the model group were given intragastric administration of the same volume of deionized water. Blood samples were collected and examined 24 hours after the last injection. Serum ALT and AST were measured in both tests,liver and spleen were collected and weighed to calculate organ index,and pathological changes of liver tissues were observed. Results:In the protective effect test of acute liver injury,the serum ALT and AST of each administration group were significantly lower than that of the model group,and the spleen index of each administration group was significantly reduced,and the degree of liver injury was significantly reduced. In the liver fibrosis protective effect test,the serum ALT and AST in Huangjiaruangan granules high-dose and medium-dose groups were significantly lower than that in the model group,and the liver index in the mediumdose group was significantly lower. Conclusion:Huangjiaruangan granule has a certain protective effect on acute liver injury and liver fibrosis in mice.

Key words:Huangjiaruangan granules,galactosamine,concanavalin A(Con A),acute liver injury,liver fibrosis,protection

中图分类号:

Baidu
map